Advertisement

Ads Placeholder
Loading...

MPH Health Care AG

93M1.DEXETRA
Healthcare
Drug Manufacturers - Specialty & Generic
18.90
-0.25(-1.31%)
German Market opens in 1h 3m

MPH Health Care AG Fundamental Analysis

MPH Health Care AG (93M1.DE) shows weak financial fundamentals with a PE ratio of -0.70, profit margin of 1.59%, and ROE of -47.72%. The company generates $-0.1B in annual revenue with weak year-over-year growth of -15.55%.

Key Strengths

PEG Ratio0.00

Areas of Concern

ROE-47.72%
Operating Margin1.59%
Cash Position3.28%
Current Ratio0.40
We analyze 93M1.DE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -26.5/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-26.5/100

We analyze 93M1.DE's fundamental strength across five key dimensions:

Efficiency Score

Weak

93M1.DE struggles to generate sufficient returns from assets.

ROA > 10%
-52.66%

Valuation Score

Excellent

93M1.DE trades at attractive valuation levels.

PE < 25
-0.70
PEG Ratio < 2
0.00

Growth Score

Weak

93M1.DE faces weak or negative growth trends.

Revenue Growth > 5%
-15.55%
EPS Growth > 10%
8.41%

Financial Health Score

Moderate

93M1.DE shows balanced financial health with some risks.

Debt/Equity < 1
0.06
Current Ratio > 1
0.40

Profitability Score

Weak

93M1.DE struggles to sustain strong margins.

ROE > 15%
-4771.61%
Net Margin ≥ 15%
1.59%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is 93M1.DE Expensive or Cheap?

P/E Ratio

93M1.DE trades at -0.70 times earnings. This suggests potential undervaluation.

-0.70

PEG Ratio

When adjusting for growth, 93M1.DE's PEG of 0.00 indicates potential undervaluation.

0.00

Price to Book

The market values MPH Health Care AG at 0.39 times its book value. This may indicate undervaluation.

0.39

EV/EBITDA

Enterprise value stands at -1.89 times EBITDA. This is generally considered low.

-1.89

How Well Does 93M1.DE Make Money?

Net Profit Margin

For every $100 in sales, MPH Health Care AG keeps $1.59 as profit after all expenses.

1.59%

Operating Margin

Core operations generate 1.59 in profit for every $100 in revenue, before interest and taxes.

1.59%

ROE

Management delivers $-47.72 in profit for every $100 of shareholder equity.

-47.72%

ROA

MPH Health Care AG generates $-52.66 in profit for every $100 in assets, demonstrating efficient asset deployment.

-52.66%

Following the Money - Real Cash Generation

Operating Cash Flow

MPH Health Care AG generates limited operating cash flow of $3.59M, signaling weaker underlying cash strength.

$3.59M

Free Cash Flow

MPH Health Care AG generates weak or negative free cash flow of $1.02M, restricting financial flexibility.

$1.02M

FCF Per Share

Each share generates $0.24 in free cash annually.

$0.24

FCF Yield

93M1.DE converts 1.26% of its market value into free cash.

1.26%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.70

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.002

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.39

vs 25 benchmark

P/S Ratio

Price to sales ratio

-1.11

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.06

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.40

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.48

vs 25 benchmark

ROA

Return on assets percentage

-0.53

vs 25 benchmark

ROCE

Return on capital employed

-0.55

vs 25 benchmark

How 93M1.DE Stacks Against Its Sector Peers

Metric93M1.DE ValueSector AveragePerformance
P/E Ratio-0.7028.54 Better (Cheaper)
ROE-47.72%738.00% Weak
Net Margin158.74%-43982.00% (disorted) Strong
Debt/Equity0.060.34 Strong (Low Leverage)
Current Ratio0.402806.01 Weak Liquidity
ROA-52.66%-14624.00% (disorted) Weak

93M1.DE outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews MPH Health Care AG's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

-3.15%

Industry Style: Defensive, Growth, Innovation

Declining

EPS CAGR

189.29%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

197.47%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ